Athens Stock Exchange movers — 19/11/2026
54 stocks rose and 45 fell; the General Index rose 0.65%. The biggest gainers came from Banks - Regional (OPTIMA, EUROB).
The session in brief
updated 18:03The General Index closed at 2601.23, up 0.65% (16.72 points), after consecutive down sessions. Of 129 stocks traded, 54 rose, 45 fell and 30 were unchanged, and the larger companies' median move was 0%. Financial Services was the strongest sector, with a median of +0.92%, as the banks gained and won back part of their losses from the previous two sessions. Reports credited Optima Bank (+2.54%) and Eurobank (+2.52%) with lifting the index back to its earlier level. The rise was described as an upward reaction after the previous day's sharp fall. Evrofarma rose 13.49%, the session's biggest gain, as investors welcomed its cooperation with Danone. The advance later narrowed as European markets gave up their opening gains. A further rise in oil and hawkish Fed rhetoric kept uncertainty alive. Healthcare (−0.48%) and Industrials (−0.34%) had the weakest sector medians. Profile Software (−3.00%), Alpha Real Estate Services (−2.88%) and Athens International Airport (−2.70%) led the decliners.
Source: pelop.gr · pelop.gr · ot.gr · businessdaily.gr
Gainers43
Top 20 by % change- EVROF3.5× volEvrofarma€4.88+13.49%3.5×
- OPTIMAOptima Bank€14.93+2.54%1.1×
- EUROBEurobank€4.803+2.52%1.4×
- FRIGOFrigoglass€0.364+2.25%0.5×
- BOCHGRBank of Cyprus€10.80+1.98%0.6×
- ELHAElvalHalcor€3.615+1.97%1.8×
- GEKTERNAGEK Terna€43.58+1.82%1.7×
- EXAEEuronext Athens€11.40+1.79%0.8×
- CAIROMEZ4.0× volCairo Mezz€0.296+1.72%4.0×
- ALWNAllwyn (ex-OPAP)€9.712+1.59%1.1×
- ATTICAAttica Group€1.390+1.46%0.7×
- QUESTQuest€7.25+1.40%0.7×
- YKNOTY/Knot Invest€1.465+1.38%0.8×
- FLEXOFlexopack€7.90+1.28%1.3×
- ETENational Bank of Greece€16.805+1.27%1.1×
- PETRO2.1× volPetros Petropoulos€6.46+1.25%2.1×
- LAVILavipharm€1.490+1.22%0.1×
- DOTSOFT56× volDotsoft€34.00+1.19%56×
- TPEIRPiraeus Bank€9.84+1.13%0.5×
- AEMAlter Ego Media€6.48+1.09%0.9×
Sectors
median moveUnusual volume
vs 10-day averageFree beta · daily MENTOR usage
Why they moved
The reason behind each move, from a published source, checked before it went up here.
Evrofarma jumped 13.49% as investors welcomed its cooperation with Danone, which Danone announced the same day.
naftemporiki.gr · 19/11/2026
Optima Bank rose 2.54% as the banks gained and won back part of their losses from the previous two sessions. Reports credited it and Eurobank with lifting the index back to its earlier level.
ot.gr · 19/11/2026
Eurobank rose 2.52% as the banks recovered, and reports credited it and Optima with lifting the index back to its earlier level. Earlier selling had centred on Eurobank after its agreement to buy a stake in Bulgaria's First Investment Bank. It stayed in focus ahead of its upcoming capital increase and its interim dividend, announced on 18 November.
ot.gr · 19/11/2026
Allwyn Q3 2026 (group, unaudited): net revenue €1,220 million vs €1,023 million (+19.3%; +4% on a comparable basis including PrizePicks, consolidated since 16 January 2026). Adjusted EBITDA €396 million vs €374 million (+6%). Adjusted profit attributable to shareholders €141 million vs €134 million (+5%). Outlook: "At Group level, we continue to expect Net Revenue growth in 2026 in the mid-to-high 20%s before one-off effects of around -2% in Continental Europe, equivalent to around €60 million." (translated) Adjusted EBITDA outlook confirmed within market consensus.
athens.euronext.com · 19/11/2026
Ideal Holdings 9M 2026 (group): revenue €412.5 million (9M 2025: €334.4 million, +23.4%), helped by the full consolidation of BARBA STATHIS Group; EBITDA €50.7 million (€43.0 million, +17.9%); profit before tax €19.4 million (€13.1 million, +48.1%); net profit €11.5 million (€7.6 million, +51.3%). Comparable EBT €30.1 million, up 28%. Outlook: "As we approach the end of the financial year, our nine-month performance supports our expectations for 2026."
athens.euronext.com · 19/11/2026
Lavipharm group 9M 2026: net sales €55.09 million (9M 2025: €41.61 million, +32.4%); EBIT €6.79 million (€5.73 million); net profit €4.02 million (€3.51 million). Adjusted EBITDA from continuing operations €10.71 million, up 12.5% from €9.52 million. Net debt €38.04 million. 9M 2025 figures included a €0.94 million gain from the sale of the pharmacy network. Outlook: "Strong sales growth is expected to continue in the last quarter of the year, both in domestic prescription drugs and in exports."
athens.euronext.com · 19/11/2026
Cenergy Holdings (group), 9M 2026: revenue €1,783,366 thousand vs €1,546,491 thousand (+15.3%); EBITDA €311,423 thousand vs €259,423 thousand (+20.0%); net profit €186,358 thousand vs €147,694 thousand (+26.2%). Order backlog a record EUR 5.2 billion, from ca. EUR 3.9 billion three months earlier. Outlook: “Cenergy Holdings upgrades its FY 2026 adjusted EBITDA guidance to EUR 415 – 430 million, from the previous interval of EUR 390 – 420 million.”
athens.euronext.com · 19/11/2026
No published cause yet. PROF -3.00%, ASTAK -2.88%, AIA -2.70%, IATR -2.17%, CAIROMEZ +1.72%, DOTSOFT +1.19%, FAIS +0.80%